Exam quality of ultrasound and dynamic contrast-enhanced abbreviated MRI and impact on early-stage HCC detection
Abdominal Radiology · 2024
DOI: 10.1007/s00261-024-04674-1 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Abdominal Radiology, 2024. Verfasst von Karim Seif El Dahan und 9 weiteren Autor:innen. Beteiligte Einrichtung: The University of Texas Southwestern Medical Center, Dallas, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Contrast Media, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Cancer Prevention and Research Institute of Texas, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
PURPOSE: MRI is a potential alternative to ultrasound for hepatocellular carcinoma (HCC) detection. We evaluated the impact of ultrasound and dynamic abbreviated MRI (AMRI) exam quality on early-stage HCC detection. METHODS: We conducted a multicenter case-control study among patients with cirrhosis (cases with early-stage HCC per Milan Criteria; controls without HCC) who underwent both a liver ultrasound and dynamic contrast-enhanced (DCE) AMRI within 6 months in 2012-2019. Two radiologists performed independent, blinded interpretations of both exams for HCC detection and scored exam quality as no/mild, moderate, or severe limitations. Associations between exam quality, patient characteristics, and HCC detection were assessed by odds ratios (OR). RESULTS: Of 216 cases and 432 controls, severe limitations were reported in 7% and 8% of ultrasounds and DCE-AMRIs, respectively. Severe limitations at ultrasound were associated with obesity (OR 2.08, 95%CI [1.32-3.32]) and metabolic dysfunction-associated steatotic liver disease (MASLD) (OR 1.98 [1.12-3.44]) but not for DCE-AMRI. Decompensated cirrhosis (Child-Pugh C) was associated with severe limitations for both ultrasound (OR 2.54 [1.37-4.58]) and DCE-AMRI (OR 3.96 [2.36-6.58]). Compared to exams with no/mild limitations, exams with severe limitations had lower sensitivity for ultrasound (79.6% vs. 21.7%, P < 0.001) and AMRI (86.1% vs. 50.0%, P = 0.001). In patients in whom ultrasound was severely limited, DCE-AMRI had significantly higher odds of early-stage HCC detection than ultrasound (OR 8.23 [1.25-54.02]). CONCLUSIONS: HCC detection by DCE-AMRI may be preferred in patients with severe limitations at ultrasound due to obesity and MASLD. Both modalities remain limited for patients with decompensated cirrhosis, for whom alternative strategies may be needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The University of Texas Southwestern Medical Center, Dallas, USA.
- University of Michigan-Ann Arbor, Ann Arbor, USA.
- The University of Texas Southwestern Medical Center, Dallas, USA. amit.singal@utsouthwestern.edu.
Förderung
- Cancer Prevention and Research Institute of Texas
- NIH HHS
- National Institutes of Health
Zitieren
APA
Seif El Dahan, K., Yokoo, T., Mendiratta-Lala, M., Fetzer, D., Davenport, M., Daher, D., Rich, N. E., Yang, E., Parikh, N. D., & Singal, A. G. (2024). Exam quality of ultrasound and dynamic contrast-enhanced abbreviated MRI and impact on early-stage HCC detection. Abdominal Radiology. https://doi.org/10.1007/s00261-024-04674-1
Vancouver
Seif El Dahan K, Yokoo T, Mendiratta-Lala M, Fetzer D, Davenport M, Daher D, et al. Exam quality of ultrasound and dynamic contrast-enhanced abbreviated MRI and impact on early-stage HCC detection. Abdominal Radiology. 2024. doi:10.1007/s00261-024-04674-1
BibTeX
@article{SeifElDahan2024,
author = {Seif El Dahan, Karim and Yokoo, Takeshi and Mendiratta-Lala, Mishal and Fetzer, David and Davenport, Matthew and Daher, Darine and Rich, Nicole E and Yang, Edward and Parikh, Neehar D and Singal, Amit G},
title = {Exam quality of ultrasound and dynamic contrast-enhanced abbreviated MRI and impact on early-stage HCC detection},
journal = {Abdominal Radiology},
year = {2024},
doi = {10.1007/s00261-024-04674-1}
}
EUVIMED